Prosecution Insights
Last updated: October 04, 2026

Patent Law Works, LLP

Technology area: Biotechnology & Pharmaceuticals

47 pending office actions • 36 clients • 45 examiners • 29 art units • 0 of 47 (0%) have an AI response strategy ready

Analysis

Patent Law Works, LLP manages 1778 career applications in the Biotechnology & Pharmaceuticals technology area. The firm has a resolved allowance rate of 87.64 percent. On average, it takes 3.63 office actions per allowance to reach a grant.

The firm currently has 38 pending office actions. This number of active cases is part of its work with 1778 career applications. The 87.64 percent resolved allowance rate highlights the firm's effectiveness in the Biotechnology & Pharmaceuticals field. The 3.63 average office actions per allowance provides a metric for the expected duration of the prosecution cycle. This firm's data shows a practice with 1778 career applications and a success rate of 87.64 percent. The 87.64 percent resolved allowance rate is an indicator of the firm's performance for clients in Biotechnology & Pharmaceuticals. With 38 pending office actions, the firm remains active in its primary technology area. The 3.63 average office actions per allowance is a consistent factor in its prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1778 apps, methodology: how we score firms)

87.6%
Allowance Rate
n=1778
+0.66σ
Allowance Rate (norm)
n=1778
3.6
OAs to Allowance
n=1049
-0.12σ
OAs to Allow (norm)
n=1049
1036 days
Time to Allowance
n=1049
+13.9pp
Interview Lift
n=1778
34.9%
RCE Rate
n=1778
0.8%
Appeal Rate
n=1778

Rejection Performance (% of received rejections ultimately overcome)

76.5%
§101 Overcome
n=298
78.1%
§102 Overcome
n=439
78.3%
§103 Overcome
n=728
73.3%
§112 Overcome
n=554

Specialization & Scale

G06F, G06Q, A61K
Top CPC Subclasses
24%
Top-3 CPC Share
n=1778
3
Practitioners
n=1778
592.7
Apps / Practitioner
n=1778

Portfolio Summary

47
Total Pending OAs
26
Non-Final OAs
18
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
0
Due this week
2
Due this month
3
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 30 days (2)Due ≤ 60 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

25
Hard (53%)
15
Medium (32%)
7
Easy (15%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other9 (19%)
§103 only9 (19%)
§102 only2 (4%)
§112 only6 (13%)
Double-patenting only1 (2%)
Double-patenting + other4 (9%)
Multi-statute (no §101)16 (34%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

24
Life Sciences
51% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
2% of docket
9
Mechanical / Eng
19% of docket
13
Business / Other
28% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

470 h
Manual time on pending OAs
94 h
Time saved (low, 20%)
164 h
Time saved (mid, 35%)
4.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SULLIVAN, THOMAS J 2 27.2% +21.2%
LI, RUIXIANG 2 59.5% +18.6%
THOMPSON, KENNETH L 1 87.4% +6.7%
CHANNAVAJJALA, SRIRAMA T 1 74.4% +32.7%
AKOGYERAM II, NICHOLAS A 1 26.7% +29.5%
ROANE, AARON F 1 73.4% +9.7%
DEMEREE, CHRISTOPHER R 1 68.9% +14.1%
PURDY, KYLE A 1 41.0% +35.9%
CHANG, AUDREY Y 1 46.5% +20.4%
DEERY, ERIN LEAH 1 58.3% +49.1%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19294816 Method and System for Controlling a Plurality of Drill Rigs THOMPSON, KENNETH L 9d overdue

Hard Cases (25)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18688085 Methods for Isolation of Lipid-Disc Compositions and Uses Thereof STEVENS, MARK V 67d overdue
18575056 A Flexible and Stretchable Cover for Attaching a Component to a Patch CHA, CASEY GEORGE 4d overdue
18552827 Vaccine Compositions for Trypanosomatids GRASER, JENNIFER E 3d overdue
18687284 Automated Parcel Buffering System TAWFIK, SAMEH 2d overdue
18004719 METHODS FOR IDENTIFYING CORONAVIRUS CROSS-REACTING ANTIBODIES WANG, RUIXUE 33d
18263934 Cell Clusters Comprising Stem and Islet Cells, Methods of Making, and Treatment of Diabetes Mellitus Therewith BEHARRY, ZANNA MARIA 36d
18569805 Compositions Comprising Microbes and Methods of Use and Making Thereof CRUM, MARY ABOU NADER 47d
18805393 Predicting Climate Event Occurrences and Damage Using Property Features and Artificial Intelligence KWONG, CHO YIU 70d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18359483 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF LI, RUIXIANG 23d overdue
19270324 Query-Time Data Sessionization and Analysis CHANNAVAJJALA, SRIRAMA T —
19235555 System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces SULLIVAN, THOMAS J —
19215220 System and Methods Integrating Distributed Machine Learning Layers for Processing Multimodal Data Sets in Real Time to Optimize Outcomes AKOGYERAM II, NICHOLAS A —
19056706 System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces SULLIVAN, THOMAS J —
19099436 A Food Box DEMEREE, CHRISTOPHER R —
18997284 Species-Specific Tissue Culture Medium for the Propagation of Cells PURDY, KYLE A —
18991000 Head-Mounted Display with Volume Substrate-Guided Holographic Continuous Lens Optics CHANG, AUDREY Y —

Client Portfolio (36 clients)

Top Art Units

Art UnitApps
16323
16743
16132
16812
16432
36761
36891
37921
16111
36931

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19294816 Method and System for Controlling a Plurality of Drill Rigs Technological Resources Pty Limited THOMPSON, KENNETH L 3676 DP Final Rejection 9d overdue Pending Aug 08, 2025
19270324 Query-Time Data Sessionization and Analysis Imply Data, Inc. CHANNAVAJJALA, SRIRAMA T §103 Final Rejection — Pending Jul 15, 2025
19235555 System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces Zelig Technology, LLC SULLIVAN, THOMAS J 3689 §103§112 Non-Final OA — Pending Jun 11, 2025
19215220 System and Methods Integrating Distributed Machine Learning Layers for Processing Multimodal Data Sets in Real Time to Optimize Outcomes Cormetrix Inc. AKOGYERAM II, NICHOLAS A §101§103§112 Non-Final OA — Pending May 21, 2025
19104936 Spinal Cord Stimulation Device Reach Neuro, Inc. ROANE, AARON F 3792 §103 Final Rejection 3d overdue Pending Feb 19, 2025
19056706 System and Methods for Creating E-Commerce Virtual Experiences And Integrating Graphical User Interfaces Zelig Technology, LLC SULLIVAN, THOMAS J §101§103 Non-Final OA — Pending Feb 18, 2025
19099436 A Food Box Tria Pte. Ltd. DEMEREE, CHRISTOPHER R §102§112 Non-Final OA — Pending Jan 28, 2025
18997284 Species-Specific Tissue Culture Medium for the Propagation of Cells SymbioCellTech, LLC PURDY, KYLE A 1611 §103 Non-Final OA — Pending Jan 21, 2025
18991000 Head-Mounted Display with Volume Substrate-Guided Holographic Continuous Lens Optics Luminit LLC CHANG, AUDREY Y §102§103§112 Non-Final OA — Pending Dec 20, 2024
18868632 Automated Toilet System Gmat Ventures, LLC DEERY, ERIN LEAH §103§112 Non-Final OA — Pending Nov 22, 2024
18847148 Novel Microbial Composition and Methods of Use Thereof Pendulum Therapeutics, Inc. IANNUZO, NATALIE NMN §102§103§112 Non-Final OA — Pending Sep 13, 2024
18844200 Delivery Shaft Assembly for Delivery of an Implant Istar Medical ZIMBOUSKI, ARIANA §112 Non-Final OA — Pending Sep 05, 2024
18805393 Predicting Climate Event Occurrences and Damage Using Property Features and Artificial Intelligence Zesty.Ai, Inc. KWONG, CHO YIU 3693 §101§112 Non-Final OA 70d Pending Aug 14, 2024
18835833 A System For Delivering Food To A Customer And A Method Thereof Clean Eats & Co. Pte. Ltd. RODRIGUEZ, JOSEPH C §103§112 Non-Final OA — Pending Aug 05, 2024
18725409 Products and Methods for Improving Plant Growth Features Aphea.Bio NV PAGUIO FRISING, MICHELLE F 1613 §101§102§112 Non-Final OA — Pending Jun 28, 2024
18652767 Mobile Printing Robot and Printing Methods with Line Printing Pathway Optimization Dusty Robotics, Inc. RICHMOND, SCOTT A. 2853 §103 Non-Final OA — Pending May 01, 2024
18600428 Means and Methods for Improved Regeneration UNIVERSITEIT GENT COLLINS, CYNTHIA E 1662 §102§103§112DP Non-Final OA — Pending Mar 08, 2024
18688938 Therapeutic Engineered Microbial Cell Systems and Methods for Treating Conditions in Which Oxalate is Detrimental Unlocked Labs Inc. STAVROU, CONSTANTINA E 1632 §102 Non-Final OA — Pending Mar 04, 2024
18688085 Methods for Isolation of Lipid-Disc Compositions and Uses Thereof Vrije Universiteit Brussel STEVENS, MARK V 1613 §101§103§112 Final Rejection 67d overdue Pending Feb 29, 2024
18687284 Automated Parcel Buffering System Box Bot Inc. TAWFIK, SAMEH 3731 §102§103 Non-Final OA 2d overdue Pending Feb 27, 2024
18444591 Grouping and Recommendations System and Method Renaissance Learning, Inc. HEWITT II, CALVIN L 4100 §101§102§103§112 Non-Final OA — Pending Feb 16, 2024
18684059 Oligonucleotides for Modulating Synaptogyrin-3 Expression Jay Therapeutics KONOPKA, CATHERINE ANNE §101§102§103§112DP Non-Final OA — Pending Feb 15, 2024
18290670 Biomarkers for Therapy Response After Immunotherapy Asylia Diagnostics BV YU, TIAN NMN 1681 §101§102§112 Non-Final OA — Pending Jan 19, 2024
18577903 Yeast Single Nucleotide Polymorphisms for Industrially Relevant Phenotypes The Board Of Trustees Of The Leland Stanford Junior University CHONG, KIMBERLY §102§112 Non-Final OA — Pending Jan 09, 2024
18575056 A Flexible and Stretchable Cover for Attaching a Component to a Patch Datwyler Pharma Packaging Belgium NV CHA, CASEY GEORGE 3794 §103§112 Final Rejection 4d overdue Pending Dec 28, 2023
18545557 Secure Payments Using a Mobile Wallet Application Minkasu, Inc. XIAO, ZESHENG 3698 §103 Final Rejection 29d Pending Dec 19, 2023
18570876 Means and Methods to Regulate Gut Dysbiosis UNIVERSITEIT GENT LEWIS, PATRICK T 1691 §112 Final Rejection — Pending Dec 15, 2023
18569805 Compositions Comprising Microbes and Methods of Use and Making Thereof Pendulum Therapeutics, Inc. CRUM, MARY ABOU NADER 1657 §102§112Other Non-Final OA 47d Pending Dec 13, 2023
18516777 Novel Antigen-Binding Chimeric Proteins and Methods and Uses Thereof Vrije Universiteit Brussel LI, RUIXIANG 1674 §102§112Other Non-Final OA — Pending Nov 21, 2023
18497332 Detection of Cancer in Urine Nanomed Diagnostics B.V. GREENE, CAROLYN LEE 1681 §102§103 Final Rejection — Pending Oct 30, 2023
35522743 Packaging for foodstuffs Tria Pte. Ltd. DIEHL, JOAN ELIZABETH 2923 §112 Non-Final OA 21d Pending Oct 25, 2023
18553044 Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses Thereof UNIVERSITE LIBRE DE BRUXELLES FAN, LYNN Y 1759 §103§112 Non-Final OA — Pending Sep 28, 2023
18552827 Vaccine Compositions for Trypanosomatids UNIVERSITEIT ANTWERPEN GRASER, JENNIFER E 1645 §103§112 Final Rejection 3d overdue Pending Sep 27, 2023
18547111 Cation-Independent Mannose-6-Phosphate Receptor Binders UNIVERSITEIT GENT CHASE, CAROL ANN 1646 §102§103§112DP Non-Final OA — Pending Aug 18, 2023
18547065 Harvester Cutter Ehs Manufacturing Pty Ltd. WEBB, SUNNY DANIELLE 3671 §103 Non-Final OA — Pending Aug 18, 2023
18546682 Inhibition of SLC4A4 in the Treatment of Cancer Katholieke Universiteit Leuven HAM, JIEUN 1643 §103§112Other Final Rejection — Pending Aug 16, 2023
18263934 Cell Clusters Comprising Stem and Islet Cells, Methods of Making, and Treatment of Diabetes Mellitus Therewith SymbioCellTech, LLC BEHARRY, ZANNA MARIA 1632 §102§112 Non-Final OA 36d Pending Aug 02, 2023
18359483 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF The Board Of Trustees Of The Leland Stanford Junior University LI, RUIXIANG 1674 §112Other Final Rejection 23d overdue Pending Jul 26, 2023
18004719 METHODS FOR IDENTIFYING CORONAVIRUS CROSS-REACTING ANTIBODIES Leyden Laboratories B.V. WANG, RUIXUE 1672 §101§103§112 Final Rejection 33d Pending Jan 09, 2023
18048946 TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS UNIVERSITEIT GENT PAK, MICHAEL D 1674 §112DP Non-Final OA — Pending Oct 24, 2022
17801921 Leucine-Rich Repeat Kinase 2 Allosteric Modulators DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E.V. BRISTOL, LYNN ANNE 1643 §112 Final Rejection 23d overdue Pending Aug 24, 2022
17787880 Compositions Comprising Microbes and Methods of Use and Making Thereof Pendulum Therapeutics, Inc. EIX, EMILY FAY 1653 §102Other Final Rejection — Pending Jun 21, 2022
17620208 CROSSLINKABLE HYDROGEL COMPOSITIONS ETH ZÜRICH ARMSTRONG, SUSANNAH SIPPLE 1616 §103DP Final Rejection — Pending Dec 17, 2021
17607334 CHIMERIC PROTEINS AND METHODS TO SCREEN FOR COMPOUNDS AND LIGANDS BINDING TO GPCRS Confo Therapeutics N.V. REYNOLDS, FRED H 1658 §112 Final Rejection 98d overdue Pending Oct 28, 2021
17507570 Trocar Device and System and Method for Monitoring Navigation of the Trocar Device Ottosurgical Instruments LLC LOUIS, RICHARD G 3771 §103 Final Rejection 184d overdue Pending Oct 21, 2021
17604284 MICROBIAL COMPOSITIONS AND METHODS FOR GREATER TOLERABILITY AND PROLONGED SHELF LIFE Pendulum Therapeutics, Inc. SPANGLER, JOSEPH RANKIN 1656 §103Other Final Rejection 104d overdue Pending Oct 15, 2021
16620326 EX VIVO MEAT PRODUCTION Wild Type, Inc. JOHNSON, KARA D 1632 §103 Non-Final OA 139d overdue Pending Dec 06, 2019

Managing Patent Law Works, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month